See more : Waystar Holding Corp. (WAY) Income Statement Analysis – Financial Results
Complete financial analysis of Prenetics Global Limited (PRE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Prenetics Global Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- SentinelOne, Inc. (S) Income Statement Analysis – Financial Results
- Tungkong Inc. (002117.SZ) Income Statement Analysis – Financial Results
- Exelon Corporation (EXC) Income Statement Analysis – Financial Results
- SHAMROCK INDUSTRIAL CO.LTD. (SHAMROIN.BO) Income Statement Analysis – Financial Results
- Thai Optical Group Public Company Limited (TOG.BK) Income Statement Analysis – Financial Results
Prenetics Global Limited (PRE)
About Prenetics Global Limited
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 21.74M | 275.76M | 275.85M | 65.18M | 9.23M |
| Cost of Revenue | 12.91M | 144.21M | 169.72M | 38.83M | 6.52M |
| Gross Profit | 8.83M | 131.55M | 106.13M | 26.34M | 2.72M |
| Gross Profit Ratio | 40.61% | 47.71% | 38.47% | 40.42% | 29.41% |
| Research & Development | 11.66M | 15.52M | 10.56M | 2.78M | 2.99M |
| General & Administrative | 41.44M | 96.06M | 83.99M | 16.62M | 13.19M |
| Selling & Marketing | 8.24M | 13.30M | 21.93M | 6.49M | 4.77M |
| SG&A | 49.68M | 109.36M | 105.92M | 23.11M | 17.96M |
| Other Expenses | -606.84K | -149.23M | -7.93K | -513.86K | 40.15K |
| Operating Expenses | 60.74M | 124.88M | 116.48M | 25.38M | 20.94M |
| Cost & Expenses | 73.65M | 269.09M | 286.20M | 64.21M | 27.46M |
| Interest Income | 3.92M | 472.19K | 3.98K | 8.04K | 15.51K |
| Interest Expense | 119.66K | 3.99M | 228.18K | 59.57K | 69.39K |
| Depreciation & Amortization | 7.79M | 7.54M | 7.35M | 2.43M | 2.23M |
| EBITDA | -47.90M | -214.28M | -157.70M | -1.42M | -18.57M |
| EBITDA Ratio | -220.29% | 15.67% | -58.89% | -0.87% | -200.54% |
| Operating Income | -51.91M | 207.42M | -10.35M | 967.46K | -18.23M |
| Operating Income Ratio | -238.73% | 75.22% | -3.75% | 1.48% | -197.44% |
| Total Other Income/Expenses | -4.76M | -159.80M | -159.89M | -2.91M | -69.39K |
| Income Before Tax | -56.67M | -183.31M | -170.28M | -3.90M | -20.87M |
| Income Before Tax Ratio | -260.64% | -66.47% | -61.73% | -5.99% | -226.06% |
| Income Tax Expense | -269.36K | 7.15M | 3.73M | -1.94M | -677.47K |
| Net Income | -62.72M | -190.45M | -174.02M | -1.96M | -20.20M |
| Net Income Ratio | -288.48% | -69.06% | -63.08% | -3.01% | -218.73% |
| EPS | -5.58 | -37.57 | -14.77 | -0.27 | -2.73 |
| EPS Diluted | -5.58 | -37.57 | -14.77 | -0.27 | -2.73 |
| Weighted Avg Shares Out | 11.25M | 5.07M | 11.78M | 7.40M | 7.40M |
| Weighted Avg Shares Out (Dil) | 11.25M | 5.07M | 11.78M | 7.40M | 7.40M |
Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
CHARLOTTE, N.C., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Prenetics' IM8 is excited to announce that its groundbreaking month-long space experiment, in partnership with the University of Oxford and supported by Space Applications Services and Metavisionaries, is now underway aboard the...
Prenetics Announces Participation in December Investor Conferences
CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team will participate in two upcoming investor conferences.
ROCKETFUEL PRE-ANNOUNCES RECORD GROWTH IN Q1-Q3 2024.
San Francisco, CA, Dec. 02, 2024 (GLOBE NEWSWIRE) -- RocketFuel Blockchain, Inc. (OTC: RKFL) (“RocketFuel” or the “Company”), a global provider of payment solutions via FIAT, Bitcoin and other cryptocurrencies, provided a pre-announcement of expected revenue for its first three quarters...
Prenetics Announces Third Quarter 2024 Financial Results
Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially
MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced Prenetics' acquisition of Europa, one of the largest sports nutrition...
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced Prenetics' acquisition of Europa, one of the largest sports nutrition...
Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference
CHARLOTTE, N.C., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, announced today that management will participate in the Sidoti Virtual Micro Cap Conference being held on November 13-14, 2024.
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
Europa Is One of the Largest Sports Nutrition Distributors With a Network of 10,000+ Gyms Across the United States Supports Prenetics' New Health and Wellness Brand IM8 with David Beckham as its Co-Founding Partner Projected Revenue of $100 Million+ in...
Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
LOS ANGELES, July 11, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, is proud to announce that former international footballer, entrepreneur and philanthropist David Beckham has become a strategic investor in the business. Prenetics and Beckham will become...
Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness
Source: https://incomestatements.info
Category: Stock Reports